Investor Presentation
Investment Highlights
OPERATIONAL IMPROVEMENTS HAVE TRANSLATED TO DRAMATICALLY IMPROVED FINANCIAL PERFORMANCE
In million of dollars
2022
2023
YoY%
Total Revenue
$87.7
$97.3
11%
Adjusted EBITDA
(1)
$25.1
$27.2
8%
CANSORTIUM IS CAPITALIZING ON THIS SUCCESS AND PLAYING OFFENSE
■
Sixth largest dispensary/retail footprint in Florida, which has one of the country's largest state medical cannabis programs
Investing to expand Florida's cultivation and dispensary network, and recently increased retail operations in Pennsylvania
First-mover advantage in Texas provides high-value optionality
Seeking strategic partnerships to accelerate near-term growth opportunities
(1)
Adjusted EBITDA is a non-IFRS financial measures that does not have any standardized meaning prescribed by IFRS and may not be comparable to
similar measures presented by other companies.
FLUENT
Investor Presentation 13View entire presentation